glp 1 and breast feeding Can you take GLP-1 while breastfeeding? What the research actually shows GLP-1 experience while breastfeeding?

Although the FDA has approved Resmetirom as a new treatment option, 661 lifestyle interventions targeting NAFLD/NASH risk factors, such as weight loss through a healthy diet and physical activity, are expected to remain central to improving patient outcomes

2023 NEJM) showed semaglutide reduced major cardiovascular events by 20% in adults with overweight and prior cardiovascular disease, which is one reason labs matter for risk stratification What About the SELECT Trial and Cardiovascular Risk

Clinical data shows that nausea affects between 2030% of semaglutide users, making it one of the most common early side effects

It is also the best IV mixture that can help to lighten skin tone and treat hyperpigmentation